NCT06786572

Brief Summary

This pilot randomized controlled trial will compare a novel mindfulness training to interoceptive exposure to establish feasibility and acceptability as an intervention for anxiety sensitivity.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
10mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Sep 2025Mar 2027

First Submitted

Initial submission to the registry

January 6, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 22, 2025

Completed
8 months until next milestone

Study Start

First participant enrolled

September 10, 2025

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2027

Last Updated

February 2, 2026

Status Verified

November 1, 2025

Enrollment Period

1.6 years

First QC Date

January 6, 2025

Last Update Submit

January 28, 2026

Conditions

Keywords

anxiety sensitivitymindfulnessinteroception

Outcome Measures

Primary Outcomes (5)

  • Enrollment rate

    Number enrolled out of number approached

    Typically up to 3 months, from initial referral to decision to enroll or not

  • Attendance

    Average number of sessions attended

    During the six-week intervention period

  • Clinician's judgment of proportion of completion of at home assignments

    Clinician's judgment of proportion of completion of at home assignments on a scale including none, partial and complete

    During the six-week intervention period

  • Client Satisfaction Questionnaire-4 (CSQ-4)

    The CSQ-4 is a validated measure of participant satisfaction with care delivered with higher scores (range 4-16) indicating greater satisfaction.

    Week 6, following the final treatment session

  • Reliable change

    Proportion improved, unchanged and worsened based on the Reliable Change Index using the Overall Anxiety Symptoms and Impairment Scale (OASIS).

    Over a 6-8 week period from baseline to post-treatment

Study Arms (2)

Interoceptive Training Enhanced Mindfulness (ITEM)

EXPERIMENTAL

Brief mindfulness training focused on management of unwanted internal sensations

Other: Mindfulness training

Interoceptive Exposure (IE)

ACTIVE COMPARATOR

Cognitive behavioral intervention featuring systematic exposure to unwanted internal sensations

Behavioral: Interoceptive exposure

Interventions

Brief mindfulness training focused on management of unwanted internal sensations

Interoceptive Training Enhanced Mindfulness (ITEM)

Cognitive behavioral therapy focused in interoceptive exposure to unwanted internal sensations

Interoceptive Exposure (IE)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Veteran status
  • able to read and speak English
  • ASI-3 score of 23 or higher
  • clinically meaningful distress/impairment related to an emotional or somatic complaint as determined by a Clinical Global Impression Scale (CGI) of 3 or greater
  • Internet access via a device that can support remote study activities and ability to attend in person appointments

You may not qualify if:

  • serious mental illness, including bipolar disorder or psychotic illness
  • current, untreated alcohol or substance use disorder
  • moderate-severe suicidality that would likely result in the need for urgent intervention in the next 2 months
  • current regular meditation practice or treatment for AS-related condition
  • cognitive dysfunction that interferes with the ability to engage in treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA San Diego Healthcare System

San Diego, California, 92161, United States

RECRUITING

Central Study Contacts

Ariel J Lang, PhD, MPH

CONTACT

Jafer Vazquez Alcaraz

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 6, 2025

First Posted

January 22, 2025

Study Start

September 10, 2025

Primary Completion (Estimated)

March 31, 2027

Study Completion (Estimated)

March 31, 2027

Last Updated

February 2, 2026

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

Final datasets in machine-readable format will be shared via PubMed Central

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Available 3/31/28, indefinite
Access Criteria
Public access
More information

Locations